These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Therapeutic drug monitoring and pharmacokinetic dose prediction methods. Oellerich M Wien Klin Wochenschr Suppl; 1992; 191():12-5. PubMed ID: 1509745 [TBL] [Abstract][Full Text] [Related]
23. Accuracy of 11 methods for predicting theophylline dose. Rodvold KA; Paloucek FP; Zell M Clin Pharm; 1986 May; 5(5):403-8. PubMed ID: 3720210 [TBL] [Abstract][Full Text] [Related]
24. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation]. Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347 [TBL] [Abstract][Full Text] [Related]
25. Nonlinear regression program to individualize oral theophylline dosage. Bauer LA; Black DJ; Koup JR Clin Pharm; 1984; 3(3):288-90. PubMed ID: 6547379 [TBL] [Abstract][Full Text] [Related]
26. Prediction of steady-state plasma theophylline concentration by Bayesian algorithm. Imaeda N; Takagi K; Hasegawa T; Saito H; Mizukami Y Int J Clin Pharmacol Ther Toxicol; 1988 Dec; 26(12):588-93. PubMed ID: 3209276 [TBL] [Abstract][Full Text] [Related]
27. Theophylline levels after single daily and divided dosing of a once-a-day theophylline preparation in asthmatic children. Boner AL; Sette L; Vallone G; Plebani M; Messori A Ann Allergy; 1989 Feb; 62(2):149-53. PubMed ID: 2919803 [TBL] [Abstract][Full Text] [Related]
29. An updated comparison of drug dosing methods. Part II: Theophylline. Erdman SM; Rodvold KA; Pryka RD Clin Pharmacokinet; 1991 Apr; 20(4):280-92. PubMed ID: 1903683 [TBL] [Abstract][Full Text] [Related]
30. The effect of dosing time on the pharmacokinetics and pharmacodynamics of a 'once-a-day' sustained release theophylline preparation. Lamont H; Pauwels R; Van der Straeten M Br J Clin Pharmacol; 1987 Dec; 24(6):735-42. PubMed ID: 3440095 [TBL] [Abstract][Full Text] [Related]
31. Predictive performance of the Bayesian analysis: effects of blood sampling time, population parameters, and pharmacostatistical model. Tanigawara Y; Yano I; Kawakatsu K; Nishimura K; Yasuhara M; Hori R J Pharmacokinet Biopharm; 1994 Feb; 22(1):59-71. PubMed ID: 8027949 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration. Steinijans VW; Sauter R; Böhm A; Staudinger H Arzneimittelforschung; 1988 Aug; 38(8A):1241-50. PubMed ID: 3190813 [TBL] [Abstract][Full Text] [Related]
33. Comparison of clinical effects and pharmacokinetics of once-daily Uniphyl and twice-daily Theo-Dur in asthmatic patients. Fairshter RD; Bhola R; Thomas R; Wilson AF; Hyatt J; Snapp S; Cummins L Am J Med; 1985 Dec; 79(6A):48-53. PubMed ID: 4083298 [TBL] [Abstract][Full Text] [Related]
34. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline. Sallent J; Hill M; Stecenko A; McKenzie M; Hendeles L Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577 [TBL] [Abstract][Full Text] [Related]
35. Once daily theophylline: multiple-dose comparison of an encapsulated micro-osmotic system (Euphylong) with a tablet (Uniphyllin). Steinijans VW; Schulz HU; Beier W; Radtke HW Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):438-47. PubMed ID: 3759279 [TBL] [Abstract][Full Text] [Related]
36. Serum theophylline profile with once-daily theophylline (Uniphyl) following conversion from intravenous theophylline in adult asthmatic patients. Fradette M; Babich M; Friesen EG; Archibald JS; Babul N Clin Ther; 1994; 16(2):160-8. PubMed ID: 8062311 [TBL] [Abstract][Full Text] [Related]
37. Once-daily dosing of a new ultrasustained-release theophylline preparation. Van den Brande P; Nys J; Tjandramaga TB; Verhelst F; Demedts M Respiration; 1987; 52(2):144-53. PubMed ID: 3671893 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of theophylline pharmacokinetics in a pediatric population using mixed effects models. Driscoll MS; Ludden TM; Casto DT; Littlefield LC J Pharmacokinet Biopharm; 1989 Apr; 17(2):141-68. PubMed ID: 2795453 [TBL] [Abstract][Full Text] [Related]
39. Effect of gallbladder contraction induced cholagogia on the pharmacokinetic profile of a sustained-release theophylline formulation. Fuchs WS; von Nieciecki A; Molz KH; Popescu G; Weil A; Barkworth MF; Gay S; Laicher A; Stanislaus F Arzneimittelforschung; 1996 Dec; 46(12):1120-6. PubMed ID: 9006785 [TBL] [Abstract][Full Text] [Related]
40. Disposition and clinical pharmacokinetics of theophylline after administration of a new sustained release tablet. Jonkman JH; Berg WC; de Vries K; de Zeeuw RA; Schoenmaker R; Grimberg N Eur J Clin Pharmacol; 1981; 21(1):39-44. PubMed ID: 7333345 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]